All Posts
July 26, 2026
China's Top 10 Critical Care Medicine Hospitals (2023 Fudan Rankings)
A patient's guide to the leading intensive care (ICU) hospitals in China based on the 2023 Fudan rankings, with strengths in sepsis and multi-organ support.
Read more →
July 25, 2026
At 70, with a 20-Year TB History: How His AML Was Cured
A 70-year-old man with two decades of pulmonary TB overcame relapsed AML through a matched unrelated donor stem cell transplant at Lu Daopei Hospital.
Read more →
July 24, 2026
CyberKnife for Brain Tumors: A Radiation Oncologist's In-Depth Explanation
How CyberKnife robotic radiosurgery treats brain tumors non-invasively, illustrated by three real brain metastasis cases with strong follow-up outcomes.
Read more →July 23, 2026
Progress in Minimally Invasive Cardiovascular Surgery in China
An overview of how minimally invasive cardiovascular surgery (MICS) has advanced across valve, arrhythmia, bypass, and aortic procedures in China.
Read more →July 22, 2026
Minimally Invasive Technology in Orthopedic Trauma
A case of minimally invasive closed reduction and intramedullary nailing for a difficult distal tibial fracture, and why the technique speeds healing.
Read more →July 21, 2026
HSCT Explained: Fully Matched, Haploidentical, and Unrelated Donors
A clear guide to hematopoietic stem cell transplantation and HLA matching, explaining related, unrelated, fully matched, and haploidentical donors.
Read more →July 20, 2026
Hospital Guide: Shanghai Ninth People's Hospital
A guide to Shanghai Ninth People's Hospital, a world leader in stomatology, plastic and reconstructive surgery, and orthopedics, for international patients.
Read more →July 19, 2026
From Wheelchair to Walking: A POEMS Syndrome Patient's Rebirth
Ms. W regained the ability to walk after an autologous stem cell transplant for rare POEMS syndrome at Shanghai Xindaopei Hematology Hospital.
Read more →July 18, 2026
Hospital Guide: Raffles Medical Group (China)
A guide to Raffles Medical Group in China, bringing Singapore-standard healthcare, direct insurance billing, and bilingual care to major Chinese cities.
Read more →July 17, 2026
Trametinib (Mekinist) — MEK Inhibitor for BRAF V600-Mutated Cancer
Trametinib inhibits MEK1/2 in the MAPK pathway, effective in melanoma and lung cancer with BRAF V600 mutations. Usually combined with Dabrafenib.
Read more →July 17, 2026
Hospital Guide: Jiahui Health
A guide to Jiahui Health, a JCI-accredited, MGH-partnered international hospital network in Shanghai offering CAR-T, robotic surgery, and bilingual care.
Read more →July 16, 2026
Enzalutamide (Xtandi) — Androgen Receptor Inhibitor for Castration-Resistant Prostate Cancer
Enzalutamide potently inhibits the androgen receptor (AR), remaining effective even when plasma testosterone is at castrate levels. A key option in advanced prostate cancer.
Read more →